A meta-analysis of the prospective Reykjavik study, comprising 1925 persons who had primary nonfatal MI or died of CAD during a follow-up (median 19.4 years), and 3616 controls, showed that the baseline plasma levels of vWF were higher in patients with CAD than in the control group [66]. This evidence concerns the gene VWF and coronary artery disorder.